F. Mehl

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
F. Mehl, Florence Mehl
Publication record
36 papers · 1,179 citations · H-index 18

PAPERS

Multi-omics subgroups associated with glycaemic deterioration in type 2 diabetes: an IMI-RHAPSODY Study
20247 citationsauthor #13
A Federated Database for Obesity Research: An IMI-SOPHIA Study
20242 citationsauthor #17
Identification of biomarkers for glycaemic deterioration in type 2 diabetes
202330 citationsauthor #39
364-OR: Unsupervised Approach Systematically Analyzes the Multiomics Profiles Associated with T2D Insulin Insensitivity—An IMI-RHAPSODY Study
20230 citationsauthor #14
Regenerating islet-derived protein 3α: A promising therapy for diabetes. Preliminary data in rodents and in humans
20222 citationsauthor #5
Novel biomarkers for glycaemic deterioration in type 2 diabetes: an IMI RHAPSODY study
20213 citationsauthor #33
Multi-omics profiling of living human pancreatic islet donors reveals heterogeneous beta cell trajectories towards type 2 diabetes
2021103 citationsauthor #6
Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study
202160 citationsauthor #16
Distinct Molecular Signatures of Clinical Clusters in People With Type 2 Diabetes: An IMI-RHAPSODY Study
202142 citationsauthor #18
Two lipidomics data sources for the publication "Multi-omics profiling of living human pancreatic islet donors reveals heterogeneous beta cell trajectories toward type 2 diabetes"
20210 citationsauthor #6
Plasma triacylglycerols are biomarkers of β-cell function in mice and humans
202119 citationsauthor #9
Cross-sectional multi-omics insight from islet and plasma samples into the progression to type 2 diabetes in metabolically profiled pancreatectomised surgical donors
20200 citationsauthor #6
Replication and cross-validation of T2D subtypes based on clinical variables: an IMI-RHAPSODY study
20203 citationsauthor #16
MetaNetX/MNXref - unified namespace for metabolites and biochemical reactions in the context of metabolic models
202073 citationsauthor #3
MetaNetX/MNXref: unified namespace for metabolites and biochemical reactions in the context of metabolic models
2020107 citationsauthor #3
Author Correction: Mechanistic insights into bacterial metabolic reprogramming from omics-integrated genome-scale models
202011 citationsauthor #6
Molecular Biomarkers of Neovascular Age-Related Macular Degeneration With Incomplete Response to Anti-Vascular Endothelial Growth Factor Treatment
202018 citationsauthor #9
Multi-omics profiling of living human pancreatic islet donors reveals heterogeneous beta cell trajectories toward type 2 diabetes
202012 citationsauthor #6
Systemic and central nervous system metabolic alterations in Alzheimer’s disease
2019192 citationsauthor #4
Mechanistic insights into bacterial metabolic reprogramming from omics-integrated genome-scale models
201943 citationsauthor #6
Merged Targeted Quantification and Untargeted Profiling for Comprehensive Assessment of Acylcarnitine and Amino Acid Metabolism.
201941 citationsauthor #4
P4‐193: IDENTIFICATION AND COMPREHENSIVE CHARACTERIZATION OF CNS AND SYSTEMIC METABOLIC ALTERATIONS IN ALZHEIMER'S DISEASE
20180 citationsauthor #3
LC-HRMS data as a result of untargeted metabolomic profiling of human cerebrospinal fluid
20182 citationsauthor #1
A global HILIC-MS approach to measure polar human cerebrospinal fluid metabolome: Exploring gender-associated variation in a cohort of elderly cognitively healthy subjects.
201863 citationsauthor #3
Longitudinal monitoring of endogenous steroids in human serum by UHPLC-MS/MS as a tool to detect testosterone abuse in sports
201562 citationsauthor #2
Integrating metabolomic data from multiple analytical platforms for a comprehensive characterisation of lemon essential oils
201517 citationsauthor #1
Evaluation of chemical contamination of surfaces during the preparation of chemotherapies in 24 hospital pharmacies
201528 citationsauthor #3
Comprehensive profiling and marker identification in non-volatile citrus oil residues by mass spectrometry and nuclear magnetic resonance.
201432 citationsauthor #3
Synthesis and in vitro evaluation of tropane halogenated-derivatives against malaria, sleeping sickness, Chagas disease and leishmaniasis.
20147 citationsauthor #3
Comparison of liquid chromatography and supercritical fluid chromatography coupled to compact single quadrupole mass spectrometer for targeted in vitro metabolism assay.
201442 citationsauthor #2
Differentiation of lemon essential oil based on volatile and non-volatile fractions with various analytical techniques: a metabolomic approach.
2014111 citationsauthor #1
Exploring the hidden biosynthetic potential of fungi – Evaluation of epigenetic modifications through metabolomics
20140 citationsauthor #3
Chemometric analysis of mid infrared and gas chromatography data of Indonesian nutmeg essential oils
201332 citationsauthor #3
Optimization of the Microwave-Assisted Ortho Ester Claisen Rearrangement: Application to Monoterpenols
20106 citationsauthor #1
Optimization of the Microwave‐Assisted Orthoester Claisen Rearrangement: Application to Monoterpenols.
20100 citationsauthor #1
Hemisynthesis and odour properties of δ-hydroxy-γ-lactones and precursors derived from linalool
20109 citationsauthor #1

TIMELINE

2010 15 citations

2013 32 citations

2014 192 citations

2015 107 citations

2018 65 citations

2019 276 citations

2020 224 citations

2021 227 citations

2022 2 citations

2023 30 citations

2024 9 citations

F. Mehl

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT